Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of Translational Medicine (2015) 13:216 DOI 10.1186/s12967-015-0586-x
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2016
- Creator
-
Kober, Christina
Rohn, Susanne
Weibel, Stephanie
Geissinger, Ulrike
Chen, Nanhai G.
Szalay, Aladar A.
- URN
-
urn:nbn:de:bvb:20-opus-126517
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kober, Christina
- Rohn, Susanne
- Weibel, Stephanie
- Geissinger, Ulrike
- Chen, Nanhai G.
- Szalay, Aladar A.
- Universität Würzburg
Time of origin
- 2016
Other Objects (12)
Antigene des Vaccinia Virus
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Vaccinia-Virus: Reinigung durch Gelfiltration
Das Assembly des Vaccinia-Virus
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains=Onkolytische Virotherapie und Modulation des Tumormilieus mittels verschiedener Vaccinia-Virus-Typen
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Antigene des Vaccinia Virus
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Vaccinia-Virus: Reinigung durch Gelfiltration
Das Assembly des Vaccinia-Virus
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains=Onkolytische Virotherapie und Modulation des Tumormilieus mittels verschiedener Vaccinia-Virus-Typen
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Antigene des Vaccinia Virus
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Vaccinia-Virus: Reinigung durch Gelfiltration
Das Assembly des Vaccinia-Virus
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains=Onkolytische Virotherapie und Modulation des Tumormilieus mittels verschiedener Vaccinia-Virus-Typen
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus